MarketPulse
I

$ICLR

4 articles found
1 positive
2 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

ICON Public Limited Company Under Internal Investigation Over Revenue Recognition Controls

ICON's Audit Committee investigates revenue recognition control deficiencies from 2023-2025. Stock plunged 40% after disclosure; company delayed financials and withdrew 2025 guidance.
ICLRsecurities fraudshareholder lawsuit
BenzingaBenzinga··Vandana Singh

J&J Receives FDA Breakthrough Designation for Rybrevant Faspro in HPV-Negative Head and Neck Cancer

FDA grants J&J's Rybrevant Faspro breakthrough designation for HPV-negative head and neck cancer, potentially accelerating patient access to this new treatment option.
JNJMRKSNYTAKICLRclinical trialimmunotherapy
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Healthcare

Clinical Trial Software Market to Nearly Triple to $34.15B by 2035

Clinical trial software market projected to nearly triple to $34.15B by 2035, driven by pharmaceutical industry's digital transformation and increased adoption of AI-enabled solutions.
ORCLORCLpDTMOIQVVEEV+1regulatory compliancecloud-based solutions
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

Law Firm Launches Investigation Into GEMI Executive Departures

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.
CVNAGEMIICLRsecurities fraudclass action lawsuit